Therapies

Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer

9 days ago   |   By Xconomy

The RAS family of proteins are one of the hottest targets in cancer research despite being one of the hardest for drug hunters to hit. Revolution Medicines has raised $238 million in an IPO to finance development of therapies that it says can drug these molecules in a novel way. On Wednesday evening, Revolution priced its offering of 14 million shares at $17 each, which was the high end of its revised price range. Last week, Revolution had set a preliminary target of 10 million shares priced in the range of $14 to $16 each. On Tuesday, the Redwood City, CA-based...
Read more ...

 


Search by Tags

   Therapies      Research      Protein      Cancer      Drug      Drugs      Medicine      Boston blog main      Boston top stories      National blog main      National top stories      San Francisco      San Francisco blog main      San Francisco top stories      Amgen      Biotech      Cancer      Cancer Drugs      Clinical trials      Cobimetinib      Deals      Investing      IPO      Life Sciences      Revolution Medicines      Roche      Sanofi      The Column Group      Third Rock Ventures      University of Illinois      Venture Capital      Warp Drive Bio  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Bio Roundup: Agile Approval, Coronavirus Collabs, Spruce's $88M & More

Bio Roundup: Agile Approval, Coronavirus Collabs, Spruce's $88M & More

The price of insulin, a life-saving treatment discovered a century ago, has been a flashpoint amid the broader drug pricing debate. The FDA is trying to tame high insulin... Read more ...

MyoNet: A Transfer-learning based LRCN for Lower Limb Movement Recognition...

MyoNet: A Transfer-learning based LRCN for Lower Limb Movement Recognition and Knee Joint Angle Prediction for Remote Monitoring of Rehabilitation Progress from sEMG

The clinical assessment technology such as remote monitoring of rehabilitation progress for lower limb related ailments rely on the automatic evaluation of movement performed... Read more ...

Feasibility of using high-contrast grating as a point-of-care sensor for...

Feasibility of using high-contrast grating as a point-of-care sensor for therapeutic drug monitoring of immunosuppressants

Abstract Point-of-care testing has demonstrated great transformative potential in personalized medicine. In particular, patients undergoing transplantation require POC testing... Read more ...

Development Of Low-Cost Point-Of-Care Technologies For Cervical Cancer...

Development Of Low-Cost Point-Of-Care Technologies For Cervical Cancer Prevention Based On A Single-Board Computer

Cervical cancer disproportionally affects women in low- and middle-income countries, in part due to the difficulty of implementing existing cervical cancer screening and... Read more ...

SeaGen Adds Five Prime Therapeutics Antibodies in Licensing Deal

SeaGen Adds Five Prime Therapeutics Antibodies in Licensing Deal

Since a major restructuring at Five Prime Therapeutics in October that kicked off a wind-down of most of its research and preclinical efforts, the company has been looking to... Read more ...

Spruce Bio Raises $88M for Clinical Tests of Rare Endocrine Disease Drug

Spruce Bio Raises $88M for Clinical Tests of Rare Endocrine Disease Drug

Spruce Biosciences has raised $88 million to advance clinical testing of a drug for a rare inherited endocrine disorder that can lead to a potentially life-threatening hormonal... Read more ...

COVID-19 Vaccine Will Close in on the Spikes

COVID-19 Vaccine Will Close in on the Spikes

As epidemiologists try to stay ahead of the spread of new coronavirus COVID-19, vaccine developers, like Sanofi and Johnson & Johnson , are focusing on the “spike” proteins... Read more ...

Head of Engineering - full-time in San Diego - CP Engineers - San Diego, CA

We're assisting our Biotech client hire for a key leadership position as Head of Engineering at their San Diego location. From CP Engineers - Sat, 22 Feb 2020 04:23:11 GMT... Read more ...

Brain cells protect muscles from wasting away

Several processes in the roundworm C. elegans boost the stress response in cells, incidentally making worms resistant to a high-fat diet and extending their lifespan... Read more ...

103967 Laboratory Research Assistant

PSYCHIATRY/HNRP Salary commensurate with qualifications and experienceFiling Deadline: Fri 3/6/2020... Read more ...